Alterations in Glucose Metabolism & Metabolic Syndrome

Galen College of Nursing: Alterations in Glucose Metabolism & Metabolic Syndrome

NSG 3280 Pathophysiology I

Overview of Glucose Metabolism

  • Glucose is a primary source of energy needed by the human body. The regulation of glucose metabolism is essential for maintaining blood glucose levels within a normal range and for overall metabolic health.
  • Key organs involved in glucose metabolism include the kidneys and liver.

Regulation of Glucose Metabolism

General Mechanism
  • Human energy requirements are predominantly met by glucose and fats.
  • Glucose is produced primarily from glycogen stored in the muscles and liver.
  • The process termed glycogenolysis describes the breakdown of glycogen into glucose, facilitating maintenance of blood glucose levels.
  • Key physiological processes:
      - Eating leads to glucose being absorbed from the gastrointestinal tract and subsequently metabolized by the liver.
Glucose Transport
  • The diffusion of glucose into cells is regulated by specific glucose transporters (GLUT):
      - GLUT 1: Present in the blood-brain barrier.
      - GLUT 2: Found in the liver.
      - GLUT 3: Located in pancreatic beta cells.
      - GLUT 4: Insulin-dependent transporter found in heart, skeletal muscle, and adipose cells.

Insulin and Its Function

Insulin Production
  • Insulin is produced in the pancreas by beta (β) cells located in the islets of Langerhans. This proinsulin is cleaved to form insulin and C-peptide.
Hormonal Regulation
  • Besides insulin, the pancreas produces other hormones:
      - Alpha (α) cells secrete glucagon, which stimulates the liver to release glucose through glycogenolysis.
      - Delta (δ) cells produce somatostatin, which regulates growth hormone, while F cells produce pancreatic polypeptide.
Actions of Insulin
  • Insulin facilitates various cellular functions:
      - Promotes the entry of glucose into cells.
      - Enhances protein synthesis, preventing muscle breakdown.
      - Inhibits gluconeogenesis (conversion of glycogen to glucose).
      - Stimulates fat deposition by preventing lipolysis and inducing lipid formation, hence preventing ketosis.
      - Stimulates growth through enhancing the secretion of insulin-like growth factor 1 (IGF-1).

Normal Glucose Metabolism Process

  1. Food is consumed, converted into glucose by the stomach.
  2. Glucose enters the bloodstream.
  3. The pancreas produces insulin, facilitating glucose entry into cells.
  4. Blood glucose levels are maintained within a normal range.
Glucose Regulation in Different States
  • Fasting: Body still requires energy; hormones adjust glucose levels through gluconeogenesis and glycogenolysis.
  • Exercise: Insulin production decreases while glucagon and catecholamines increase, leading to heightened blood glucose levels. However, muscle cells show increased sensitivity to insulin for glucose uptake.

Stress Response and Glucose Metabolism

  • Stress hormones (corticosteroids and catecholamines) elevate liver glucose production and inhibit glucose utilization by promoting insulin resistance.
      - Psychological stress can similarly evoke glucose metabolism alterations.
  • Infections can cause hyperglycemia.

Glucose Intolerance Disorders

Classifications
  1. Pre-diabetes
  2. Type I Diabetes Mellitus (insulin-dependent)
  3. Type 2 Diabetes Mellitus
  4. Gestational Diabetes Mellitus (GDM)
Screening Recommendations
  • Adults over 45 years should undergo screening for type 2 diabetes every three years, or more frequently if risk factors are present.

Pre-Diabetes

Etiology/Pathogenesis
  • Characterized by impaired glucose tolerance and impaired fasting glucose (IFG).
  • Mildly elevated fasting glucose levels.
  • Development of insulin resistance occurs.
Diagnosis
  • Fasting plasma glucose: 100-125 mg/dL
  • 2-hour plasma glucose during OGTT: 140-199 mg/dL
  • HbA1c: 5.7-6.4%
Clinical Manifestations
  • Typically, individuals show no signs of symptoms, though could experience excessive thirst, polyphagia (increased hunger), and prolonged health issues over time.

Type I Diabetes Mellitus

Etiology
  • Can be immune-mediated or idiopathic, with autoimmune markers often identified on chromosome 6 (human leukocyte antigen, HLA).
  • Usually diagnosed between 5-20 years of age.
Pathogenesis
  • Characterized by autoimmune destruction of the pancreatic β cells, mediated by macrophages and T lymphocytes, resulting in insufficient insulin production and elevated plasma glucose levels.
Diagnosis
  • Must meet two of the following criteria:
      - Random blood glucose above 200 mg/dL with classic symptoms
      - Fasting glucose greater than 126 mg/dL
      - Blood glucose greater than 200 mg/dL after a 75-g oral glucose load
      - HbA1c level above 6.5%
Clinical Manifestations
  • Classic signs include polyuria, polydipsia, polyphagia, glucosuria, fatigue, sudden weight loss, prolonged wound healing, blurry vision, and potential numbness/tigling sensations in extremities.

Type II Diabetes Mellitus

Etiology/Pathogenesis
  • Most common form of diabetes, exact causes vary but often involve insulin resistance in peripheral tissues and β cell dysfunction.
  • Risk factors include obesity, family history, age, high blood pressure, sedentary lifestyle, and ethnic backgrounds among others.
  • As the disease progresses, insulin production may further decline.
Screening
  • Similar criteria for diagnosis, emphasizing the importance of assessing fasting glucose and HbA1c levels.
Clinical Manifestations
  • Symptoms may be subtle or absent. Notably, insulin deficiency may lead to non-healing lesions on toes/feet due to poor circulation.

Gestational Diabetes Mellitus

Etiology/Pathogenesis
  • Characterized by glucose intolerance that arises during pregnancy.
  • Insulin resistance is exacerbated by placental hormones and weight gain.
Risk Factors
  • Includes severe obesity, prior gestational diabetes history, and ethnic backgrounds such as African American, Hispanic, Asian, and Native American.
Diagnosis
  • Screening should occur post-pregnancy confirmation, especially in high-risk women, and must happen between 24–28 weeks gestation.

Metabolic Syndrome

Etiology/Pathogenesis
  • Defined as a cluster of biochemical and physiological abnormalities that increase the likelihood of cardiovascular disease and type 2 diabetes.
  • Risk factors include age, sedentary lifestyle, and certain ethnic groups, notably Native Americans and Hispanic Americans.
Clinical Manifestations
  • Excess abdominal fat is highlighted with increased risks for complications like insulin resistance, hypertension, hyperglycemia, and dyslipidemia.

References

  • Banasik, J. L. (2022). Pathophysiology (7th ed.). Elsevier.